Use of High-Resolution Structural MRI to Assess Changes in Brain Structure Related to Chemotherapy in Patients with Non-Small Cell Lung Cancer: A Prospective Study
[Protocol 11-145] |
Root, James, PhD |
A Survey of Psychosocial Needs and Exploration of Online Support for Patients with Pleural Mesothelioma
[Protocol 11-066] |
Key, Richard, MD |
A Pilot Study of a Breathing Training Exercise to Reduce Chronic Shortness of Breath
[Protocol 12-261] |
Deng, Gary, MD, PhD |
A Phase III Study of Sublobar Resection versus Stereotactic Body Radiation Therapy in High-Risk Patients with Stage I Non-Small Cell Lung Cancer
[Protocol 13-003] |
Gelblum, Daphna, MD |
A Phase III Study of Everolimus versus Placebo in Patients with Neuroendocrine Tumors Originating in the Lungs or Gastrointestinal Tract: The RADIANT-4 Study
[Protocol 12-250] |
Reidy-Lagunes, Diane, MD |
A Phase III Study of Etoposide/Platinum with and without Ipilimumab in Patients with Newly Diagnosed Advanced Small Cell Lung Cancer
[Protocol 12-202] |
Pietanza, M. Catherine, MD |
A Phase III Study of BMS-936558 versus Docetaxel in Patients with Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer
[Protocol 12-252] |
Rizvi, Naiyer, MD |
A Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide
[Protocol 11-003] |
Rimner, Andreas, MD |
A Phase II Toxicity Study Using Chemotherapy Followed By Intensity Modulated Radiation Therapy to the Pleura in Patients with Locally Advanced Unresectable Malignant Pleural Mesothelioma
[Protocol 08-053] |
Krug, Lee, MD |
A Phase II Study of WT-1 Analog Peptide Vaccine in Patients with Malignant Pleural Mesothelioma
[Protocol 10-134] |
Krug, Lee, MD |
A Phase II Study of Temozolomide Alone or with ABT-888 (Veliparib) in Patients with Relapsed or Refractory Small Cell Lung Cancer
[Protocol 12-021] |
Pietanza, M. Catherine, MD |
A Phase II Study of Neoadjuvant Pemetrexed Plus Cisplatin for Patients with Resectable Non-Squamous Non-Small Cell Lung Cancer with "Switch Chemotherapy Alternative" in Non-Responders (NEOSCAN)
[Protocol 11-106] |
Chaft, Jamie, MD |
A Phase II Study of GSK2118436 in Patients with Advanced Non-Small Cell Lung Cancer and BRAF Mutations
[Protocol 11-023] |
Riely, Gregory, MD, PhD |
A Phase II Study of Dasatinib in Patients with Advanced Non-Small Cell Lung Cancers with DDR2 or Inactivating BRAF Mutations
[Protocol 12-163] |
Paik, Paul, MD |
A Phase II Study of Cabozantinib in Patients with Advanced Non-Small Cell Lung Cancer
[Protocol 12-097] |
Rizvi, Naiyer, MD |
A Phase II Study of Bortezomib in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[Protocol 12-222] |
Riely, Gregory, MD, PhD |
A Phase II Study of BMS-936558 in Patients with Previously Treated Advanced Squamous Cell Lung Cancer
[Protocol 12-284] |
Rizvi, Naiyer, MD |
A Phase II Study of BKM120 in Patients with Metastatic Non-Small Cell Lung Cancer
[Protocol 11-157] |
Paik, Paul, MD |
A Phase II Study Evaluating Manuka Honey to Reduce Chemoradiation-Associated Esophagitis Pain during Lung Cancer Treatment
[Protocol 12-111] |
Rimner, Andreas, MD |
A Phase IB/II Study of IPI-504 plus Everolimus in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[Protocol 11-114] |
Riely, Gregory, MD, PhD |
A Phase IB Study of BKM120 plus MEK162 in Select Patients with Advanced Solid Tumors
[Protocol 11-117] |
Gounder, Mrinal, MD |
A Phase I/II Trial of AUY-922 in Patients with Lung Adenocarcinoma with Acquired Resistance to Erlotinib or Gefitinib
[Protocol 11-015] |
Riely, Gregory, MD, PhD |
A Phase I/II Study of Crizotinib and STA-9090 in ALK-Positive Lung Cancers
[Protocol 12-015] |
Riely, Gregory, MD, PhD |
A Phase I Study of SNX-5422 plus Erlotinib in Patients with Lung Cancer that Has Grown on Erlotinib Therapy
[Protocol 13-035] |
Riely, Gregory, MD, PhD |
A Phase I Study of LDK378 in Adults with Non-Small Cell Lung Cancers Containing an ALK Gene Fusion
[Protocol 11-055] |
Riely, Gregory, MD, PhD |
A Phase I Study of LDE225 with Etoposide and Cisplatin for the Initial Treatment of Extensive Small Cell Lung Cancer
[Protocol 11-206] |
Pietanza, M. Catherine, MD |
A Phase I Study of GL-ONC1 for Treating Malignant Pleural Effusion
[Protocol 12-169] |
Rusch, Valerie, MD |
A Phase I Study of BMS-986015 with Ipilimumab in Patients with Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Melanoma
[Protocol 12-283] |
Rizvi, Naiyer, MD |
A Phase I Study of BMS-986015 plus BMS-936558 in Patients with Advanced Solid Tumors
[Protocol 12-224] |
Segal, Neil, MD, PhD |
A Phase I Study of BMS-936558 with Combination Chemotherapy for Patients with Previously Untreated Stage IIIB or IV Non-Small Cell Lung Cancer
[Protocol 11-189] |
Rizvi, Naiyer, MD |
A Phase I Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancer
[Protocol 11-170] |
Paik, Paul, MD |
A Phase I Study of Afatinib with Chemotherapy and Radiation Therapy in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
[Protocol 12-279] |
Chaft, Jamie, MD |
